Diabetes drug tested to help heal damaged hearts after major attack
NCT ID NCT07169981
Summary
This study tested if a diabetes medication called Empagliflozin could help improve the structure and pumping ability of the heart in people with diabetes who had a serious heart attack. It involved 200 participants who received one of two doses of the drug and were monitored for 6 months with heart scans. The goal was to see if the drug could help the heart recover better and reduce future heart problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ain Shams University Hospitals
Cairo, Egypt
Conditions
Explore the condition pages connected to this study.